Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1
Public ClinicalTrials.gov record NCT02660138. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to provide confirmatory evidence of the safety and efficacy of two Dysport® (AbobotulinumtoxinA) doses (600 units \[U\] and 800 U), compared to placebo in reducing urinary incontinence (UI) in adult subjects treated for neurogenic detrusor overactivity (NDO) due to spinal cord injury (SCI) or multiple sclerosis (MS).
Study identification
- NCT ID
- NCT02660138
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 227 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2016 (Type not available)
- Primary completion
- Nov 9, 2018 (Actual)
- Completion
- Feb 14, 2019 (Actual)
- Last update posted
- Sep 28, 2022
2016 – 2019
United States locations
- U.S. sites
- 32
- U.S. states
- 22
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB School of Medicine Spain Rehabilitation Center (SRC) | Birmingham | Alabama | 35249 | — |
| Urological Associates of Southern Arizona, P.C. | Tucson | Arizona | 85715-3808 | — |
| Atlantic Urology Medical Group | Long Beach | California | 90806 | — |
| USC Norris Comprehensive Cancer Center | Los Angeles | California | 90089 | — |
| UC Davis Medical Center | Sacramento | California | 95817-2307 | — |
| University of Colorado Denver | Aurora | Colorado | 80045-2527 | — |
| Women's Health Specialty Care | Farmington | Connecticut | 06032-1933 | — |
| Gousse Urology - The Bladder Heath and Reconstructive Urology Institute | Miramar | Florida | 33029-5593 | — |
| The Iowa Clinic, PC | West Des Moines | Iowa | 50266 | — |
| Chesapeake Urology Associates, PA | Owings Mills | Maryland | 21117 | — |
| University of Michigan Hospital | Ann Arbor | Michigan | 48109 | — |
| Weill Cornell Medical College | Denville | New Jersey | 07834 | — |
| Delaware Valley Urology,IIC | Voorhees Township | New Jersey | 08043 | — |
| Urology Group of New Mexico, PC | Albuquerque | New Mexico | 87109 | — |
| New York University Langone Medical Center and School of Medicine | New York | New York | 10016 | — |
| New York-Presbyterian Hospital/Weill Cornell Medical Center | New York | New York | 10065 | — |
| Advanced Urology Centers of New York | Plainview | New York | 11783 | — |
| Montefiore Medical Center | The Bronx | New York | 10461 | — |
| University of North Carolina School of Medicine | Chapel Hill | North Carolina | 27599 | — |
| Levine Cancer Institute | Charlotte | North Carolina | 28207 | — |
| Louis Stokes Cleveland Veterans Affairs Medical Center | Cleveland | Ohio | 44106 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Lancaster Urology | Lancaster | Pennsylvania | 17601 | — |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Medical University of South Carolina (MUSC) | Charleston | South Carolina | 29425 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Urology Clinics of North Texas | Dallas | Texas | 75231 | — |
| Houston Methodist Hospital | Houston | Texas | 77030 | — |
| Lahey Hospital & Medical Center | Burlington | Vermont | 01805-0001 | — |
| Urology of Virginia, PLLC | Virginia Beach | Virginia | 23462-1815 | — |
| Integrity Medical Research | Mountlake Terrace | Washington | 98043 | — |
| Medical College of Wisconsin - Freodert Hospital | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02660138, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 28, 2022 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02660138 live on ClinicalTrials.gov.